CNRS USR 3078, Institut de Recherche Interdisciplinaire, Campus CNRS de la Haute Borne, Université Lille Nord de France, IFR 147, BP 70478, Villeneuve d'Ascq, France.
PLoS One. 2013;8(2):e55883. doi: 10.1371/journal.pone.0055883. Epub 2013 Feb 6.
Ets-1 is a transcription factor that regulates many genes involved in cancer progression and in tumour invasion. It is a poor prognostic marker for breast, lung, colorectal and ovary carcinomas. Here, we identified poly(ADP-ribose) polymerase-1 (PARP-1) as a novel interaction partner of Ets-1. We show that Ets-1 activates, by direct interaction, the catalytic activity of PARP-1 and is then poly(ADP-ribosyl)ated in a DNA-independent manner. The catalytic inhibition of PARP-1 enhanced Ets-1 transcriptional activity and caused its massive accumulation in cell nuclei. Ets-1 expression was correlated with an increase in DNA damage when PARP-1 was inhibited, leading to cancer cell death. Moreover, PARP-1 inhibitors caused only Ets-1-expressing cells to accumulate DNA damage. These results provide new insight into Ets-1 regulation in cancer cells and its link with DNA repair proteins. Furthermore, our findings suggest that PARP-1 inhibitors would be useful in a new therapeutic strategy that specifically targets Ets-1-expressing tumours.
Ets-1 是一种转录因子,可调节许多参与癌症进展和肿瘤侵袭的基因。它是乳腺癌、肺癌、结直肠癌和卵巢癌的预后不良标志物。在这里,我们确定多聚(ADP-核糖)聚合酶 1(PARP-1)是 Ets-1 的一种新型相互作用伙伴。我们表明,Ets-1 通过直接相互作用激活 PARP-1 的催化活性,然后以非依赖于 DNA 的方式进行多聚(ADP-核糖)化。PARP-1 的催化抑制增强了 Ets-1 的转录活性,并导致其大量积累在细胞核中。当抑制 PARP-1 时,Ets-1 的表达与 DNA 损伤的增加相关,导致癌细胞死亡。此外,PARP-1 抑制剂仅使表达 Ets-1 的细胞积累 DNA 损伤。这些结果为癌细胞中 Ets-1 的调节及其与 DNA 修复蛋白的联系提供了新的见解。此外,我们的研究结果表明,PARP-1 抑制剂将在一种新的治疗策略中非常有用,该策略专门针对表达 Ets-1 的肿瘤。